-
SELF-REPORTED HEALTH AND FUNCTIONING STATUS AFTER AT LEAST 2 YEARS OF TOBACCO HEATING SYSTEM USE VERSUS CIGARETTE SMOKING: A CROSS-SECTIONAL STUDY
Aug 11, 2026, 17:16 PM -
COMPARING THE MEASUREMENT PROPERTIES OF EQ-5D-5L AND QLU-C10D IN CHINESE PATIENTS WITH NON-SMALL CELL LUNG CANCER
Aug 11, 2026, 17:16 PM -
VALIDATING AN APPROACH FOR RAPID EXPLORATION OF PRICE-DRIVEN CHANGES IN COST-EFFECTIVENESS RESULTS
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT OF ADDING ACORAMIDIS TO FORMULARY FOR THE TREATMENT OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A UNITED STATES HEALTH PLAN ANALYSIS
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF DIGITAL BREAST TOMOSYNTHESIS FOR BREAST CANCER SCREENING IN KOREAN WOMEN
Aug 11, 2026, 17:16 PM -
IDENTIFICATION OF PRESCRIBING CENTERS FOR RARE DISEASE DRUGS IN ITALY: REGIONAL REGULATION AND PERCEIVED IMPACT ON ACCESS
Aug 11, 2026, 17:16 PM -
VARIATION IN OBESITY BURDEN, MULTIMORBIDITY, AND HEALTHCARE COSTS ACROSS OBESITY CLASS, SEX, AND RACE/ETHNICITY IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
ECONOMIC IMPACT OF PUBLICLY FUNDED VACCINATION PROGRAMS IN AUSTRIA: RESULTS FROM A FIVE-YEAR BUDGET IMPACT ANALYSIS
Aug 11, 2026, 17:16 PM -
ARE BIOPHARMA DECISIONS BASED ON HIGH-QUALITY RWE? INSIGHTS FROM SLRS
Aug 11, 2026, 17:16 PM -
CAUSAL MACHINE LEARNING FOR HEALTH INSURANCE COVERAGE EFFECTS: FROM INDIVIDUAL TREATMENT EFFECT ESTIMATION TO POLICY OPTIMIZATION USING REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
TIME TO RESPOND? PROCEDURAL TIMELINES AND DEVELOPER PARTICIPATION IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
STRUCTURED EXPERT ELICITATION TO INFORM COST SAVINGS POTENTIALS OF A VIRTUAL TWIN FOR CAR T-CELL THERAPY FOR MULTIPLE MYELOMA
Aug 11, 2026, 17:16 PM -
HEALTH-RELATED QUALITY OF LIFE (HRQOL), HUMANISTIC AND PRODUCTIVITY BURDEN OF CAREGIVERS OF CHILDREN RECENTLY DIAGNOSED WITH TYPE 1 DIABETES (T1D): A CROSS-SECTIONAL STUDY IN THE UNITED KINGDOM (UK)
Aug 11, 2026, 17:16 PM -
ANALYSIS OF DRUG REIMBURSEMENT LISTING RATES AND EVALUATION DURATIONS BY TYPE OF ASSESSMENT IN SOUTH KOREA (2007-2025)
Aug 11, 2026, 17:16 PM -
EXCESS HEALTHCARE RESOURCE UTILISATION AND DIRECT MEDICAL COSTS ASSOCIATED WITH POTENTIALCHLAMYDIA TRACHOMATIS-RELATED SEQUELAE IN GERMANY: A REAL-WORLD EVIDENCE STUDY COVERING 2010 TO 2022
Aug 11, 2026, 17:16 PM -
RECURRENT EXCLUSION OF FORESEEABLE SAME-PAYER COSTS IN MEXICO'S HEALTH-INPUT EVALUATION: A FRAMEWORK ANALYSIS ACROSS ALZHEIMER'S DISEASE AND POST-STROKE SPASTICITY
Aug 11, 2026, 17:16 PM -
REAL-WORLD USE AND DISCONTINUATION OF HYPERTENSION THERAPIES: INSIGHTS FROM THE ENLIGHTN STUDY USING PRIMARY CARE DATA IN ITALY
Aug 11, 2026, 17:16 PM -
OPENQALY: AN OPEN-SOURCE R ECOSYSTEM FOR ACCESSIBLE, TRANSPARENT, AND REPRODUCIBLE COST-EFFECTIVENESS MODELING
Aug 11, 2026, 17:16 PM -
HEALTH-STATE COSTS OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER IN PORTUGAL BASED ON EXPERT PANEL CONSENSUS
Aug 11, 2026, 17:16 PM -
NAVIGATING JOINT SCIENTIFIC CONSULTATIONS UNDER THE EU HTA REGULATION: STRATEGIC CONSIDERATIONS FOR PARALLEL VERSUS HTA-ONLY ADVICE AND ALTERNATIVE EVIDENCE ALIGNMENT APPROACHES
Aug 11, 2026, 17:16 PM
